Bodewell OTC Eczema, Psoriasis Treatments Relaunched After P&G Ventures’ Acquisition

The line, using colloidal oatmeal for eczema, salicylic acid for psoriasis or pyrithione zinc for flaky scalp, was independently launched in beta by a Vancouver, BC, start-up in January 2020 and debuted in May that year.

• Source: Alamy (Alamy Stock Photo)

The Bodewell line of OTC monograph skin care treatments for eczema and psoriasis returns to US stores five months after Procter & Gamble acquired the brand through its P&G Ventures early-stage startup studio.

The line, using colloidal oatmeal for eczema, salicylic acid for psoriasis or pyrithione zinc for flaky scalp, was independently launched in beta by a Vancouver, BC,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Retail

More from Business